Peerbridge Health, Inc.
Developer of an ambulatory ECG wearable and cloud platform that pairs wireless patch ECG hardware with AI-based signal processing and analytics for remote cardiac and cardiopulmonary diagnostics. The company focuses on rapid, non-invasive detection and monitoring, clinical validation through large-scale trials, and deployment of cloud-based reporting for clinicians.
Industries
N/A
Nr. of Employees
small (1-50)
Peerbridge Health, Inc.
3 Columbus Circle, 15th Floor, New York, NY 10019
Patents
System and method for monitoring conditions of a subject based on wireless sensor data
US-12053302-B2
View DetailsSystem and method for monitoring conditions of a subject based on wireless sensor data
US-11622722-B2
View DetailsWireless electrode arrangement and method for patient monitoring via electrocardiography
US-9101264-B2
View DetailsWireless electrode arrangement and method for patient monitoring via electrocardiography
US-7979111-B2
View Details
System and method for monitoring conditions of a subject based on wireless sensor data
US-12053302-B2
View DetailsSystem and method for monitoring conditions of a subject based on wireless sensor data
US-11622722-B2
View DetailsWireless electrode arrangement and method for patient monitoring via electrocardiography
US-9101264-B2
View DetailsWireless electrode arrangement and method for patient monitoring via electrocardiography
US-7979111-B2
View DetailsProducts
Ambulatory ECG wearable patch
A compact wireless patch intended to record multi-lead ECG signals in outpatient and home settings with reduced-lead hardware and algorithms to derive expanded lead information and enable AI-based interpretation.
Ambulatory ECG wearable patch
A compact wireless patch intended to record multi-lead ECG signals in outpatient and home settings with reduced-lead hardware and algorithms to derive expanded lead information and enable AI-based interpretation.
Services
Design and conduct of multi‑site clinical studies for wearable ECG devices including enrollment workflows, consent, blinded analysis, and endpoint validation.
Provision of a cloud analytics workflow and clinician portal to receive, analyze, and report wearable ECG data for diagnostic and monitoring use.
Design and conduct of multi‑site clinical studies for wearable ECG devices including enrollment workflows, consent, blinded analysis, and endpoint validation.
Provision of a cloud analytics workflow and clinician portal to receive, analyze, and report wearable ECG data for diagnostic and monitoring use.
Expertise Areas
- Ambulatory ECG monitoring
- AI-driven cardiac diagnostics
- Clinical trial management and validation
- Derived-lead ECG reconstruction
Key Technologies
- Ambulatory ECG wearable sensors
- Reduced-lead to 12‑lead reconstruction algorithms
- Explainable AI for diagnostics
- Cloud-based analytics and clinician portal
News & Updates
Announcement of the COR-INSIGHT clinical trial to validate AI-enabled cardiac and cardiopulmonary diagnostics and monitoring using a wearable ECG device.
Announcement of a next-generation IoT-enabled wearable ECG device and wireless connectivity enablement to expand remote AI-driven cardiac care.
News item reporting a 95.7% success rate in an early detection heart failure trial using the remote wearable device.
Announcement covering a funding round close, a 510(k) submission for a next‑generation device, and board/leadership updates.
IRB approval recorded for the COR-INSIGHT clinical trial.
Selected for the MedTech Innovator 2025 cohort (announced on site news blocks).
Announcement of the COR-INSIGHT clinical trial to validate AI-enabled cardiac and cardiopulmonary diagnostics and monitoring using a wearable ECG device.
Announcement of a next-generation IoT-enabled wearable ECG device and wireless connectivity enablement to expand remote AI-driven cardiac care.
News item reporting a 95.7% success rate in an early detection heart failure trial using the remote wearable device.
Announcement covering a funding round close, a 510(k) submission for a next‑generation device, and board/leadership updates.
IRB approval recorded for the COR-INSIGHT clinical trial.
Selected for the MedTech Innovator 2025 cohort (announced on site news blocks).